Cramer Rosenthal Mcglynn LLC Biolife Solutions Inc Transaction History
Cramer Rosenthal Mcglynn LLC
- $1.69 Billion
- Q3 2024
A detailed history of Cramer Rosenthal Mcglynn LLC transactions in Biolife Solutions Inc stock. As of the latest transaction made, Cramer Rosenthal Mcglynn LLC holds 1,102,659 shares of BLFS stock, worth $29.3 Million. This represents 1.63% of its overall portfolio holdings.
Number of Shares
1,102,659
Previous 1,300,829
15.23%
Holding current value
$29.3 Million
Previous $27.9 Million
0.99%
% of portfolio
1.63%
Previous 1.71%
Shares
3 transactions
Others Institutions Holding BLFS
# of Institutions
198Shares Held
44.9MCall Options Held
8.2KPut Options Held
4K-
Casdin Capital, LLC New York, NY8.71MShares$232 Million16.93% of portfolio
-
Black Rock Inc. New York, NY5.49MShares$146 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA3.2MShares$85.2 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.85MShares$75.7 Million0.0% of portfolio
-
Fred Alger Management, LLC New York, NY1.58MShares$42 Million0.2% of portfolio
About BIOLIFE SOLUTIONS INC
- Ticker BLFS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 42,684,400
- Market Cap $1.13B
- Description
- BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...